Oncology Institute (TOIIW) Short-term Investments (2022 - 2024)

Oncology Institute (TOIIW) has 3 years of Short-term Investments data on file, last reported at $9.9 million in Q2 2024.

• For the quarter ending Q2 2024, Short-term Investments fell 3.42% year-over-year to $9.9 million; the trailing twelve-month figure through Jun 2024 stood at $9.9 million (down 3.42% YoY), and the FY2023 full-year result was $49.4 million, down 17.44% from the prior year.
• Short-term Investments for Q2 2024 stood at $9.9 million, down from $29.8 million in the prior quarter.
• Across five years, Short-term Investments topped out at $59.9 million in Q3 2023 and bottomed at $9.9 million in Q2 2024.
• The 3-year median for Short-term Investments is $35.0 million (2023), against an average of $36.0 million.
• The widest annual swing landed in 2023, when Short-term Investments jumped 105.38%; it then declined 25.8% in 2024.
• A 3-year view of Short-term Investments shows it stood at $59.8 million in 2022, then retreated by 17.44% to $49.4 million in 2023, then slumped by 79.87% to $9.9 million in 2024.
• The last three Short-term Investments figures came in at $9.9 million (Q2 2024), $29.8 million (Q1 2024), and $49.4 million (Q4 2023), per Business Quant data.

Peer Comparison